Related references
Note: Only part of the references are listed.Using Electronic Health Records to Derive Control Arms for Early Phase Single-Arm Lung Cancer Trials: Proof-of-Concept in Randomized Controlled Trials
Gillis Carrigan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation
Hans-Georg Eichler et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Overcoming Regulatory Aversion to Novel Methods of Evidence Generation
Elodie Baumfeld Andre et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Beyond Randomized Clinical Trials: Use of External Controls
Heinz Schmidli et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Emulation Differences vs. Biases When Calibrating Real-World Evidence Findings Against Randomized Controlled Trials
Jessica M. Franklin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Synthetic and External Controls in Clinical Trials - A Primer for Researchers
Kristian Thorlund et al.
CLINICAL EPIDEMIOLOGY (2020)
Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With Apples
Sara Lodi et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2019)
Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence
Victoria L. Bartlett et al.
JAMA NETWORK OPEN (2019)
Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017
Helen J. Curtis et al.
DIABETES OBESITY & METABOLISM (2018)
Cancer recording in patients with and without type 2 diabetes in the Clinical Practice Research Datalink primary care data and linked hospital admission data: a cohort study
Rachael Williams et al.
BMJ OPEN (2018)
Comparative effectiveness from a single-arm trial and real-world data: alectinib versus ceritinib
Jessica Davies et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2018)
Association of Second-line Antidiabetic Medications With Cardiovascular Events Among Insured Adults With Type 2 Diabetes
Matthew J. O'Brien et al.
JAMA NETWORK OPEN (2018)
Androgen Deprivation Therapy and the Risk of Anemia in Men with Prostate Cancer
Blanaid M. Hicks et al.
EPIDEMIOLOGY (2017)
A Propensity-score-based Fine Stratification Approach for Confounding Adjustment When Exposure Is Infrequent
Rishi J. Desai et al.
EPIDEMIOLOGY (2017)
Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management
Arun Chaudhury et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
GLP-1 Agonists and Blood Pressure: A Review of the Evidence
Aditya Goud et al.
CURRENT HYPERTENSION REPORTS (2016)
Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK-Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls
Daniel Shao-Weng Tan et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The Role of Nonrandomized Trials in the Evaluation of Oncology Drugs
R. Simon et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
Emily Herrett et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
Use of historical control data for assessing treatment effects in clinical trials
Kert Viele et al.
PHARMACEUTICAL STATISTICS (2014)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Validation and validity of diagnoses in the General Practice Research Database: a systematic review
Emily Herrett et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Incretin-Based Therapies Viewpoints on the way to consensus
Michael A. Nauck et al.
DIABETES CARE (2009)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Insulin resistance and cardiovascular disease
HN Ginsberg
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
